Kymera Therapeutics

KYMR

NASDAQHealth Care

Income Statement

Total Revenue$47.07M

Gross Profit$47.07M

Operating Income$-261.64M

EBITDA$-216.24M

EBIT$-223.61M

Pre-tax Income$-311.35M

Net Income$-223.86M

Cash Equivalent$103.83M

Total Debt$87.8M

Book Value$781.17M

Book Value Per Share12.55

Return on Equity (ROE)-26.79%

Return on Assets (ROA)-22.89%

Return on Invested Capital (ROI)-26.67%

Net Profit Margin-475.57%

Current Ratio7.53

Quick Ratio7.23

Long-Term Debt / Equity0.25